Seven Eight Capital’s Veracyte VCYT Stock Holding History

Seven Eight Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-40,641	Closed	-$1.12M	–	836
2023 Q4	$1.12M	Buy	+40,641	New	+$981K	0.13%	230
2023 Q2	–	Sell	-15,564	Closed	-$347K	–	664
2023 Q1	$347K	Buy	+15,564	New	+$376K	0.07%	309
2022 Q4	–	Sell	-19,671	Closed	-$327K	–	647
2022 Q3	$327K	Buy	+19,671	New	+$443K	0.07%	356
2021 Q4	–	Sell	-13,470	Closed	-$626K	–	689
2021 Q3	$626K	Sell	13,470 -11,900	-47%	-$519K	0.06%	391
2021 Q2	$1.01M	Buy	+25,370	New	+$1.08M	0.14%	256

Other funds holding VCYT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Seven Eight Capital's VCYT Position: Q1 2024 in Review

Seven Eight Capital sold out of Veracyte (VCYT) in Q1 2024, closing a stake of 40,641 shares — an estimated $1.12M sold.

Seven Eight Capital first reported a position in VCYT in Q2 2021 and held it in 5 quarters. The position peaked at $1.12M in Q4 2023. 246 funds tracked by Wall St. Rank hold VCYT as of Q1 2024.

Seven Eight Capital reported no remaining Veracyte position as of Q1 2024 after selling out during the quarter.
Seven Eight Capital sold 40,641 Veracyte shares in Q1 2024, an estimated $1.12M.
Seven Eight Capital first reported a position in Veracyte in Q2 2021 and held it in 5 quarters.
Seven Eight Capital's Veracyte position peaked at $1.12M in Q4 2023.
246 funds tracked by Wall St. Rank held Veracyte as of Q1 2024.

Based on Seven Eight Capital's 13F filing for Q1 2024, filed 13 May 2024.